New genetic test for mouth cancer

 

John von Radowitz
Thursday 04 October 2012 12:14 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

A new genetic test has been developed that can detect early signs of mouth cancer.

The qMIDS test measures the activity of 16 genes from a piece of biopsy tissue less than half the size of a grain of rice.

It can show whether patients with mouth sores or ulcers possess pre-cancerous cells.

The test had a cancer detection rate of up to 94% when used on more than 350 head and neck tissue specimens from 299 patients in the UK and Norway.

Mouth, or oral cancer, affects more than 6,200 people each year in the UK.

One of the main symptoms is mouth lesions, such as sores and ulcers. But these are very common and mostly benign - only 5% to 30% may develop into cancers.

Lead researcher Dr Muy-Teck Teh, from the Institute of Dentistry at Queen Mary, University of London, said: "A sensitive test capable of quantifying a patient's cancer risk is needed to avoid the adoption of a 'wait-and-see' intervention.

"Detecting cancer early, coupled with appropriate treatment, can significantly improve patient outcomes, reduce mortality, and alleviate long-term public healthcare costs."

The findings are published in the International Journal of Cancer.

PA

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in